570 — China Traditional Chinese Medicine Holdings Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapValue Trap

Market Cap
HK$10.42bn
Enterprise Value
HK$14.25bn
Revenue
CNY18.12bn

Annual income statement for China Traditional Chinese Medicine Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,321	14,806	19,053	14,304	18,122
Cost of Revenue
Gross Profit	8,576	9,126	11,829	7,198	9,274
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	11,860	12,316	16,300	13,240	16,695
Operating Profit	2,461	2,491	2,753	1,064	1,427
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,155	2,230	2,520	840	1,225
Provision for Income Taxes
Net Income After Taxes	1,773	1,861	2,123	721	1,396
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,588	1,663	1,933	764	1,285
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,588	1,663	1,933	764	1,285
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.317	0.342	0.387	0.182	0.254
Dividends per Share